# Inflammation REduction to Prevent cArdiovascular Injury in Renal Disease (REPAIR)

> **NCT06203977** · PHASE1 · RECRUITING · sponsor: **Hamilton Health Sciences Corporation** · enrollment: 200 (estimated)

## Conditions studied

- Chronic Kidney Diseases
- Renal Failure

## Interventions

- **DRUG:** Colchicine

## Key facts

- **NCT ID:** NCT06203977
- **Lead sponsor:** Hamilton Health Sciences Corporation
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-11-15
- **Primary completion:** 2026-05-31
- **Final completion:** 2026-05-31
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2025-03-12

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06203977

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06203977, "Inflammation REduction to Prevent cArdiovascular Injury in Renal Disease (REPAIR)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06203977. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*